Assure Tech (Hangzhou) Co., Ltd. (SHA:688075)
30.41
+0.29 (0.96%)
Sep 23, 2026, 3:00 PM CST
Assure Tech (Hangzhou) Revenue
Assure Tech (Hangzhou) had revenue of 117.66M CNY in the quarter ending June 30, 2026, with 2.80% growth. This brings the company's revenue in the last twelve months to 410.36M, down -21.43% year-over-year. In the year 2025, Assure Tech (Hangzhou) had annual revenue of 451.26M, down -16.54%.
Revenue (ttm)
410.36M
Revenue Growth
-21.43%
P/S Ratio
9.37
Revenue / Employee
716.17K
Employees
573
Market Cap
3.84B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 451.26M | -89.44M | -16.54% |
| Dec 31, 2024 | 540.70M | 37.34M | 7.42% |
| Dec 31, 2023 | 503.36M | -5.66B | -91.84% |
| Dec 31, 2022 | 6.17B | 4.58B | 287.97% |
| Dec 31, 2021 | 1.59B | 389.51M | 32.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Hefei Lifeon Pharmaceutical | 1.51B |
| Xiangxue Pharmaceutical | 1.48B |
| Pulike Biological Engineering | 1.02B |
| Beijing Bohui Innovation Biotechnology Group | 816.14M |
| Landfar Bio-medicine | 660.26M |
| Lifecome Biochemistry | 470.43M |
| Shanghai Model Organisms Center | 457.70M |
| Beijing Scitop Bio-tech | 372.08M |